Skip to main content

Table 2 Baseline clinical characteristics and procedural details in the overall population

From: Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials

Variables High-dose of RSV n/population (%) Control n/population (%)
Number of patients 1671/3273 (51.1 %) 1602/3273 (48.9 %)
Male 1150/1671 (68.8 %) 1075/1602 (67.1 %)
Hypertension 1088/1671 (65.1 %) 988/1602 (61.7 %)
Diabetes Mellitus 473/1671 (28.3 %) 449/1602 (28.0 %)
Smoker 592/1606 (36.9 %) 573/1542 (37.2 %)
Previous MI 223/1067 (20.9 %) 224/1069 (21.0 %)
Previous PCI 160/1019 (15.7 %) 143/1017 (14.1 %)
Stable angina 732/1671 (43.8 %) 657/1602 (41.0 %)
NSTEMI 759/1671 (45.4 %) 759/1602 (47.3 %)
STEMI 181/1671 (10.8 %) 188/1602 (11.7 %)
Multi-vessel disease 198/644 (30.7 %) 157/633 (24.8 %)
B2/C lesions 654/918 (71.2 %) 590/855 (69.0 %)
Thrombus 122/757 (16.1 %) 135/763 (17.7 %)
LM 16/700 (2.3 %) 25/709 (3.5 %)
LAD 666/1253 (53.2 %) 619/1174 (52.7 %)
LCX 360/1315 (27.3 %) 354/1244 (28.4 %)
RCA 393/1253 (31.4 %) 368/1174 (31.3 %)
Multiple vessel PCI 216/644 (33.5 %) 203/768 (26.4 %)
Aspirin 1624/1671 (97.2 %) 1548/1602 (96.6 %)
Clopidogrel 1599/1605 (99.6 %) 1530/1536 (99.6 %)
β-blockers 952/1393 (68.3 %) 979/1402 (69.8 %)
ACEI/ARB 910/1393 (65.3 %) 953/1402 (67.9 %)
Glycoprotein IIb/IIIa inhibitors 76/1025 (7.4 %) 103/959 (10.7 %)
Numbers of DES 560/696 (80.5 %) 556/691 (80.5 %)
  1. Previous MI previous myocardial infarction, Previous PCI previous percutaneous coronary intervention, NSTE-ACS non-ST segment elevation acute coronary syndrome, STEMI ST segment elevation myocardial infarction, LM, left main, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, DES drug-eluting stent